Notice

Funding decision on prolotherapy treatment

2,911

Views

0

Shares

The Purchasing Guidance Advisory Group has decided not to fund prolotherapy treatment, or any variation of it, as a pain management option.

The recommendation was that due to limited evidence of the treatment’s clinical effectiveness, ACC won’t be purchasing or endorsing the use of prolotherapy for any indication.

Download

June 2014 Newsletter

Published 06/06/2014

Share this